Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer

BACKGROUND: To investigate outcomes and morbidity of patients undergoing secondary cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer. MATERIALS AND METHODS: Between April 2014 and January 2019, a total of 51 recurrent ovarian cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei-Chun, Huang, Huei-Jean, Yang, Lan-Yan, Pan, Yu-Bin, Huang, Kuan-Gen, Lin, Cheng-Tao, Chen, Min-Yu, Tang, Yun-Hsin, Chang, Ting-Chang, Lai, Chyong-Huey, Chou, Hung-Hsueh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chang Gung University 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661499/
https://www.ncbi.nlm.nih.gov/pubmed/34656802
http://dx.doi.org/10.1016/j.bj.2021.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661499/
https://www.ncbi.nlm.nih.gov/pubmed/34656802
http://dx.doi.org/10.1016/j.bj.2021.10.003

Ejemplares similares